drugset / Trial / NCT03332524

Clinical Trial of the Safety and Efficacy of SP160412 in the Temporary Relief of Mild to Moderate Sunburn

NCT03332524

Phase 2 Terminated 80 enrolled Sephoris Pharmaceuticals LLC
RandomizedFactorialQuadruple-blindTreatment

Summary

A phase II multicenter, double-blinded clinical trial of the safety and efficacy of SP160412 in the temporary relief of mild to moderate, (i.e. first degree) sunburn

Timeline

Start
2018-01-15
Primary completion
2019-09-25
Completion
2019-09-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorpheniramine Unknown 4 mg Oral
Subject Ibuprofen Small molecule 400 mg Oral

Indications